Lisata Therapeutics LSTA
NASDAQ LSTA
$1.44 -0.03 (-2.04%)
At close: Sep 30, 2026 · 4:00 PM EDT

Lisata Therapeutics (LSTA) EBT Margin (2010 - 2025)

Updated

Lisata Therapeutics' EBT Margin came in at -2272.31% for Q4 2025, down 1811.31 percentage points from -461.00% a year earlier.

Analysis

Lisata Therapeutics (LSTA) EBT Margin (2010 - 2025) Analysis & Trends

For FY2025, Lisata Therapeutics' EBT Margin was -8774.00%, down 6695.70 percentage points from FY2024.

  • Going back by year, EBT Margin was -2078.30% in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 26.66%
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 25.18%
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn -4.11%
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 29.63%
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 18.19%
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 27.53%
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn -131.41%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -4.34%
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 41.75%
10 Lisata Therapeutics 13.40 Mn 13.15 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -2,272.31%
Jun 30, 2025 -6,655.71%
Dec 31, 2024 -461.00%
Mar 31, 2017 -83.76%
Dec 31, 2016 -55.68%
Sep 30, 2016 -65.37%
Jun 30, 2016 -93.16%
Mar 31, 2016 -160.15%
Dec 31, 2015 -619,862.02%
Sep 30, 2015 -192.69%
Jun 30, 2015 -355.57%
Mar 31, 2015 -604.77%
Dec 31, 2014 -226,239.78%
Sep 30, 2014 -415,960.59%
Jun 30, 2014 -283,406.22%
Mar 31, 2014 -339,809.54%
Dec 31, 2013 -304,830.38%
Sep 30, 2013 -249,038.14%
Jun 30, 2013 -187,613.51%
Mar 31, 2013 -351,201.62%
API Access

Lisata Therapeutics EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=LSTA&period=max&api_key=YOUR_API_KEY